Compare Stocks: TKNO, BLFS, FTRE, and PSNL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$37.87 +2.9%	$35.48	$17.86 ▼ $39.76	$1.86B	1.82	724,082 shs	156,747 shs
FTRE Fortrea	$19.76 +1.8%	$18.77	$8.55 ▼ $21.39	$1.88B	1.92	1.49 million shs	110,075 shs
PSNL Personalis	$16.32 +0.9%	$15.41	$4.95 ▼ $18.89	$1.71B	2.32	2.63 million shs	203,986 shs
TKNO Alpha Teknova	$8.90 +0.5%	$7.08	$1.91 ▼ $9.48	$476.06M	0.85	204,094 shs	10,250 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	-5.33%	-4.67%	+3.69%	+30.84%	+40.76%
FTRE Fortrea	-2.76%	-3.10%	+9.48%	+12.27%	+103.78%
PSNL Personalis	-0.68%	-2.41%	-5.22%	+18.72%	+134.01%
TKNO Alpha Teknova	-0.45%	-4.63%	+25.14%	+53.02%	+39.09%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$37.87 +2.9%	$35.48	$17.86 ▼ $39.76	$1.86B	1.82	724,082 shs	156,747 shs
FTRE Fortrea	$19.76 +1.8%	$18.77	$8.55 ▼ $21.39	$1.88B	1.92	1.49 million shs	110,075 shs
PSNL Personalis	$16.32 +0.9%	$15.41	$4.95 ▼ $18.89	$1.71B	2.32	2.63 million shs	203,986 shs
TKNO Alpha Teknova	$8.90 +0.5%	$7.08	$1.91 ▼ $9.48	$476.06M	0.85	204,094 shs	10,250 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	-5.33%	-4.67%	+3.69%	+30.84%	+40.76%
FTRE Fortrea	-2.76%	-3.10%	+9.48%	+12.27%	+103.78%
PSNL Personalis	-0.68%	-2.41%	-5.22%	+18.72%	+134.01%
TKNO Alpha Teknova	-0.45%	-4.63%	+25.14%	+53.02%	+39.09%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	2.09	Hold	$31.38	-17.14% Downside
FTRE Fortrea	2.33	Hold	$22.00	11.36% Upside
PSNL Personalis	2.30	Hold	$14.54	-10.93% Downside
TKNO Alpha Teknova	2.40	Hold	$8.00	-10.11% Downside

Current Analyst Ratings Breakdown

Latest TKNO, BLFS, FTRE, and PSNL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/30/2026	FTRE Fortrea	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$22.00
9/30/2026	FTRE Fortrea	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/22/2026	BLFS BioLife Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Hold (C)
9/21/2026	BLFS BioLife Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/17/2026	TKNO Alpha Teknova	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$9.00
9/17/2026	TKNO Alpha Teknova	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$9.00
9/7/2026	PSNL Personalis	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/24/2026	PSNL Personalis	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$16.25
8/11/2026	TKNO Alpha Teknova	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/11/2026	TKNO Alpha Teknova	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$8.00
8/10/2026	BLFS BioLife Solutions	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold

(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$96.21M	19.25	$0.22 per share	169.66	$7.72 per share	4.90
FTRE Fortrea	$2.72B	0.69	$9.83 per share	2.01	$6.10 per share	3.24
PSNL Personalis	$69.65M	24.54	N/A	N/A	$2.94 per share	5.55
TKNO Alpha Teknova	$40.52M	11.78	N/A	N/A	$1.28 per share	6.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$4.59M	$1.16	32.70	236.66	N/A	53.29%	2.70%	2.49%	11/5/2026 (Estimated)
FTRE Fortrea	-$986.20M	-$0.91	N/A	18.64	0.48	-3.18%	10.72%	2.17%	11/5/2026 (Estimated)
PSNL Personalis	-$81.27M	-$1.09	N/A	N/A	N/A	-153.84%	-46.47%	-35.30%	11/3/2026 (Estimated)
TKNO Alpha Teknova	-$17.26M	-$0.31	N/A	N/A	N/A	-38.37%	-24.94%	-16.53%	11/5/2026 (Estimated)

Latest TKNO, BLFS, FTRE, and PSNL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	BLFS BioLife Solutions	$0.0313	$0.91	+$0.8788	$0.91	$27.80 million	$28.47 million
8/5/2026	Q2 2026	TKNO Alpha Teknova	-$0.0843	-$0.06	+$0.0243	-$0.06	$10.95 million	$12.19 million
8/4/2026	Q2 2026	PSNL Personalis	-$0.2633	-$0.30	-$0.0367	-$0.30	$16.69 million	$22.36 million
7/29/2026	Q2 2026	FTRE Fortrea	$0.1804	$0.23	+$0.0496	-$0.14	$647.57 million	$678.20 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
FTRE Fortrea	N/A	N/A	N/A	N/A	N/A
PSNL Personalis	N/A	N/A	N/A	N/A	N/A
TKNO Alpha Teknova	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	N/A	9.69	7.14
FTRE Fortrea	1.98	0.96	0.96
PSNL Personalis	N/A	5.28	5.08
TKNO Alpha Teknova	0.21	4.49	3.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
FTRE Fortrea	N/A
PSNL Personalis	61.91%
TKNO Alpha Teknova	13.81%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
FTRE Fortrea	0.73%
PSNL Personalis	4.20%
TKNO Alpha Teknova	13.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	155	48.92 million	47.85 million	Optionable
FTRE Fortrea	14,000	95.10 million	94.41 million	Optionable
PSNL Personalis	260	104.72 million	100.32 million	Optionable
TKNO Alpha Teknova	158	53.61 million	46.54 million	Not Optionable

TKNO, BLFS, FTRE, and PSNL Headlines

Recent News About These Companies

Bank of America Corp DE Makes New $1.45 Million Investment in Alpha Teknova, Inc. $TKNO

October 2 at 3:11 AM | marketbeat.com

All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy

October 1 at 1:01 PM | zacks.com

Head-To-Head Survey: Alpha Teknova (NASDAQ:TKNO) and Icon (NASDAQ:ICLR)

September 30 at 5:00 AM | defenseworld.netD

Alpha Teknova (NASDAQ:TKNO) Sets New 1-Year High - Should You Buy?

September 25, 2026 | marketbeat.com

88,412 Alpha Teknova, Inc. $TKNO Shares Sold by Squarepoint Ops LLC

September 25, 2026 | defenseworld.netD

Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?

September 22, 2026 | zacks.com

Reviewing CryoPort (NASDAQ:CYRX) & Alpha Teknova (NASDAQ:TKNO)

September 22, 2026 | americanbankingnews.com

Jefferies initiates coverage of Alpha Teknova with buy

September 18, 2026 | msn.com

Jefferies Financial Group Upgrades Alpha Teknova (NASDAQ:TKNO) to Strong-Buy

September 18, 2026 | marketbeat.com

Teknova Unveils Fill-Tek For Customized Single-Use Reagent Orders

September 17, 2026 | rttnews.com

Alpha Teknova, Inc. (NASDAQ:TKNO) Receives Average Rating of "Hold" from Brokerages

September 17, 2026 | marketbeat.com

Teknova launches Fill-Tek dispensing system for single-use bag filling

September 16, 2026 | streetinsider.com

Alpha Teknova Introduces Fill-Tek Dispensing System to Expand Custom Single-Use Bag Reagent Manufacturing

September 16, 2026 | quiverquant.comQ

Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling

September 16, 2026 | globenewswire.com

879,786 Shares in Alpha Teknova, Inc. $TKNO Acquired by BlackRock Inc.

September 6, 2026 | marketbeat.com

Alpha Teknova: Ample Manufacturing Capacity At A High Premium

August 24, 2026 | seekingalpha.com

Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy?

August 19, 2026 | zacks.com

Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade

August 10, 2026 | zacks.com

Alpha Teknova, Inc. 2026 Q2 - Results - Earnings Call Presentation

August 9, 2026 | seekingalpha.com

Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand

August 7, 2026 | insidermonkey.com

Teknova targets less than $8M 2026 free cash outflow as it lifts revenue guide to $45M-$47M

August 6, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO, BLFS, FTRE, and PSNL Company Descriptions

BioLife Solutions NASDAQ:BLFS

$37.86 +1.09 (+2.95%)

As of 10:50 AM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Fortrea NASDAQ:FTRE

$19.76 +0.36 (+1.83%)

As of 10:49 AM Eastern

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Personalis NASDAQ:PSNL

$16.32 +0.15 (+0.93%)

As of 10:50 AM Eastern

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Alpha Teknova NASDAQ:TKNO

$8.90 +0.04 (+0.45%)

As of 10:49 AM Eastern

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TKNO, BLFS, FTRE, and PSNL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TKNO, BLFS, FTRE, and PSNL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TKNO, BLFS, FTRE, and PSNL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO, BLFS, FTRE, and PSNL Company Descriptions

BioLife Solutions NASDAQ:BLFS

Fortrea NASDAQ:FTRE

Personalis NASDAQ:PSNL

Alpha Teknova NASDAQ:TKNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TKNO, BLFS, FTRE, and PSNL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TKNO, BLFS, FTRE, and PSNL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TKNO, BLFS, FTRE, and PSNL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO, BLFS, FTRE, and PSNL Company Descriptions

BioLife Solutions NASDAQ:BLFS

Fortrea NASDAQ:FTRE

Personalis NASDAQ:PSNL

Alpha Teknova NASDAQ:TKNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools